A new mechanism is being established under Immunization Agenda 2030 (IA2030) to identify regional and country priorities for vaccine research and development (R&D). These priorities will inform Monitoring and Evaluation (M&E) for IA2030. They will also be disseminated widely to enable greater coordination among funders, researchers, vaccine developers, vaccine implementers, and other stakeholders.
The first question being addressed is What are regional and country priorities for new vaccine product R&D for endemic pathogens? Once established, this mechanism can be used for additional questions of interest to regional and global stakeholders.
For more information, email
Context and results
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Partnering with regions and countries to identify priority pathogens for vaccines, December 2023 | Vaccine Prioritization & Platforms Team | 2023 | Presentation | English |
| Partnering with regions and countries to identify priority pathogens for vaccines, October 2022 | Vaccine Prioritization & Platforms Team | 2022 | Presentation | English |
Methods
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Partnering with regions and countries to identify priority pathogens for vaccines: Update on survey preparation and dissemination, 5 December 2022 | Vaccine Prioritization & Platforms Team | 2022 | Presentation | English |
| Vaccine R&D Priorities: Initial Landscaping and Proposed Methods, for PDVAC input | Vaccine Prioritization & Platforms Team | Guidance | English | |
| Vaccine R&D Priorities: Survey Preparation and Launch, for PDVAC input (includes pathogen scoring) | Vaccine Prioritization & Platforms Team | Report | English | |
| Vaccine R&D Priorities: Survey Progress and Preliminary Results, for SAGE input | Vaccine Prioritization & Platforms Team | Report | English | |
| Vaccine R&D Priorities: Update on Pathogen Scope and Scoring, March 2024 | Vaccine Prioritization & Platforms Team | 2024 | Report | English |
| Vaccine R&D Priorities: Vaccine Use Cases and Action Categories, for PDVAC input December 2023 | Vaccine Prioritization & Platforms Team | Report | English |